Trial Outcomes & Findings for A Biologic Joint Replacement Strategy to Treat Patients With Severe Knee Trauma and Post-Traumatic Knee Osteoarthritis (NCT NCT03257371)
NCT ID: NCT03257371
Last Updated: 2021-01-26
Results Overview
patient reported Visual Analogue Scale Pain Score, 0 no pain, 10 maximum pain
COMPLETED
10 participants
12 months
2021-01-26
Participant Flow
Participant milestones
| Measure |
Post-traumatic Knee OA
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
Overall Study
STARTED
|
10
|
|
Overall Study
COMPLETED
|
9
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
| Measure |
Post-traumatic Knee OA
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
Overall Study
Lost to Follow-up
|
1
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Post-traumatic Knee OA
n=10 Participants
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=10 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
10 Participants
n=10 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=10 Participants
|
|
Age, Continuous
|
41.4 years
n=10 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=10 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=10 Participants
|
|
Region of Enrollment
United States
|
10 participants
n=10 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: 7 patients completed the study without needing revision/TKA surgery or being lost to follow-up
patient reported Visual Analogue Scale Pain Score, 0 no pain, 10 maximum pain
Outcome measures
| Measure |
Post-traumatic Knee OA
n=7 Participants
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
Visual Analogue Scale Pain Score
|
2.3 units on a scale
Interval 0.0 to 7.0
|
SECONDARY outcome
Timeframe: 12 monthsPatient reported outcome scale related to work and sporting activities, The Tegner activity scale is a one-item score that graded activity based on work and sports activities on a scale of 0 to 10. Zero represents disability because of knee problems and 10 represents national or international level soccer.
Outcome measures
| Measure |
Post-traumatic Knee OA
n=7 Participants
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
Tegner Activity Level Scale
|
3.3 units on a scale
Interval 2.0 to 4.0
|
SECONDARY outcome
Timeframe: 12 monthsKnee specific patient reported outcome, ranges from 0 to 100. This final number is interpreted as a measure of function with higher scores representing higher levels of function.
Outcome measures
| Measure |
Post-traumatic Knee OA
n=7 Participants
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
International Knee Documentation Committee (IKDC) Total Score
|
50.6 units on a scale
Interval 39.1 to 64.4
|
SECONDARY outcome
Timeframe: 12 monthsA survey related to physical function and mobility, T-score metric in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. On the T-score metric: A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. A higher score is better for this outcome measure as it indicates more function/mobility compared to the mean of the reference population.
Outcome measures
| Measure |
Post-traumatic Knee OA
n=7 Participants
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
PROMIS - Physical Function and Mobility
Physical Function
|
41.2 units on a scale
Interval 27.7 to 46.6
|
|
PROMIS - Physical Function and Mobility
Mobility
|
43.1 units on a scale
Interval 37.7 to 47.9
|
Adverse Events
Post-traumatic Knee OA
Serious adverse events
| Measure |
Post-traumatic Knee OA
n=10 participants at risk
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Revision or TKA surgery
|
20.0%
2/10 • Number of events 2 • AE data was followed for one year.
AE: I. Bleeding II. Infection III. Pain that is uncontrolled with standard post-operative analgesia protocol SAE: I. Bleeding that is significant enough to require extended hospitalization or unplanned critical care interventions II. Infection that is significant enough to require extended hospitalization or unplanned critical care interventions III. Pain that is significant enough to require extended hospitalization or unplanned critical care interventions
|
Other adverse events
| Measure |
Post-traumatic Knee OA
n=10 participants at risk
post-traumatic knee OA and requiring a tibial plateau and meniscus arthroplasty plus a femoral condyle arthroplasty
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Bone Grafting
|
10.0%
1/10 • Number of events 1 • AE data was followed for one year.
AE: I. Bleeding II. Infection III. Pain that is uncontrolled with standard post-operative analgesia protocol SAE: I. Bleeding that is significant enough to require extended hospitalization or unplanned critical care interventions II. Infection that is significant enough to require extended hospitalization or unplanned critical care interventions III. Pain that is significant enough to require extended hospitalization or unplanned critical care interventions
|
|
Musculoskeletal and connective tissue disorders
Knee Arthroscopy
|
30.0%
3/10 • Number of events 3 • AE data was followed for one year.
AE: I. Bleeding II. Infection III. Pain that is uncontrolled with standard post-operative analgesia protocol SAE: I. Bleeding that is significant enough to require extended hospitalization or unplanned critical care interventions II. Infection that is significant enough to require extended hospitalization or unplanned critical care interventions III. Pain that is significant enough to require extended hospitalization or unplanned critical care interventions
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place